Acadia Healthcare Appoints New COO as Company Plans 14 New Treatment Centers by 2024
: Acadia Healthcare (Nasdaq: ACHC), a leading name in behavioral health, has recently announced the appointment of Dr. Nasser Khan as their new Chief Operating Officer. This is a revolutionary step for the company as this role was previously not part of their C-suite. Khan, who served as the Operations Group President for the company’s Comprehensive Treatment Center (CTC) business line, officially assumed his new position on June 30 as per a Securities and Exchange Commission filing source.
Dr. Nasser Khan is a seasoned professional with a stellar track record in the healthcare industry. Prior to joining Acadia, he held the position of Senior Vice President of Operations at Shields Health Solutions, a subsidiary of Walgreens Boots Alliance (Nasdaq: WBA). Earlier in his career, Khan, a qualified physician, worked as the Head of Program and Chief Medical Officer at Biograph, a health care technology company. More about his career can be found here source.
In his new role as the COO, Khan has three main priorities: service to patients, service to staff, and improving clinical outcomes source. He believes in delivering the highest quality of care in the industry and aims to elevate the standards of service even further during his tenure.
The responsibilities of the COO role were previously carried out by the Executive Vice President of Operations, John Hollinsworth, who retired on June 30. To ensure a smooth transition of leadership, Hollinsworth will continue to serve in an advisory capacity until the end of 2024 source.
Under Khan’s guidance, Acadia Healthcare is poised to expand its CTC division. The company has grand plans to open 14 new CTCs in 2024 and has already acquired three North Carolina-based CTCs in March. This renewed focus on CTCs aligns with Acadia’s five-point strategy for growth, which includes facility expansion, de novo growth, joint venture partnerships, acquisitions, and expanding its care continuum source.
Despite experiencing weaker patient volumes than expected in the first quarter of 2024, Acadia is optimistic about meeting its full-year guidance. Along with expanding its CTC business, the company aims to grow its outpatient segment. CEO Christopher Hunter has mentioned that partial hospitalization programs (PHPs) and intensive outpatient programs (IOPs) are anticipated to be significant contributors to the business over time.
Nasser Khan’s appointment to this crucial position demonstrates Acadia Healthcare’s commitment to enhancing its service and improving patient outcomes. With his rich experience and dedication, Khan is set to steer the company towards achieving its strategic growth objectives. The future of Acadia Healthcare under Khan’s leadership is a promising one, filled with innovation and advancement in the world of behavioral health.